Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
901 to 920 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| R01NS057553 | Animal Models for Studying Human Frontotemporal Dementia | 1 | 2017 |
| R01NS059957 | Fragile X Phenotypes Modulated by Altered Signaling to the Synaptic Cytoskeleton | 1 | 2017 |
| R01NS081740 | Neurovascular Protection for Early Brain Injury after SAH | 1 | 2017 |
| R01NS082240 | Role of DNA damage in the early steps of HSV infection and latency in neurons | 1 | 2017 |
| R01NS083410 | PAR-1 Signaling and HAND | 1 | 2017 |
| R01NS085081 | Intermediate neuronal progenitors in neocortical development | 1 | 2017 |
| R01NS085207 | ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models | 1 | 2017 |
| R03CA191527 | Deletion of Arid1a and Kras as a Model of Endometriosis-Associated Ovarian Cancer | 1 | 2017 |
| R21AG050049 | Animal model of impaired autoregulation for study of age related vascular cognitive impairment | 1 | 2017 |
| R21AG053654 | Targeting Relaxin Receptor 1 for Protection of the Aging Diabetic Heart | 1 | 2017 |
| R21AI119708 | Basis of MyD88-independent Th1 immunity during Toxoplasma infection | 1 | 2017 |
| R21DA042342 | Exosomal miRNA signaling in Cocaine Addiction | 1 | 2017 |
| R21DE025726 | Facilitation of stem cell differentiation in severely injured salivary glands | 1 | 2017 |
| R25GM060201 | Initiative to Maximize Student Diversity | 1 | 2017 |
| R25GM099644 | Emory Initiative for Maximizing Student Development | 1 | 2017 |
| R37AA014372 | HCV, Alcohol and Host Defense | 1 | 2017 |
| R37HL091102 | Stem Cell Signaling in the Pathologically Challenged Myocardium | 1 | 2017 |
| RF1AG006173 | Aging in the Brain: Role of the Fibrous Proteins | 1 | 2017 |
| RF1AG051633 | The role of the renin-angiotensin-endothelial pathway in AD | 1 | 2017 |
| RF1AG055707 | Vps35 dysregulation, a mechanism of AD-like neurodegeneration and dementia in Down syndrome | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=46